Regulatory uncertainty prompts Chinese firms to rethink listing plans

A recent report suggests China’s regulatory clampdown is impacting listings and take-private deals.
New York Stock Exchange building
New York Stock Exchange building

Regulatory uncertainty is prompting Chinese firms to delist from US stock exchanges, a new report published Tuesday October 26 suggests.

The report found that seven Chinese firms with a total implied equity value of around $3.8 billion delisted from American exchanges within the first eight months of 2021, with the total market capitalisation of pending take-private deals of US-listed Chinese companies amounting to over $12 billion as of August 31, 2021.

Meanwhile, 51 initial public offerings IPOs of Chinese companies in Hong Kong raised approximately $19 billion during the same period. This comes on the back of 92 companies raising $28.1 billion on the Hong...

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 1 article from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at [email protected], or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at [email protected], or +(852) 2122 5222